Publikationen im NUM
Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.
T. Lingscheid,
L. Lippert,
D. Hillus,
T. Kruis,
C. Thibeault,
E. Helbig,
P. Tober-Lau,
F. Pfäfflin,
H. Müller-Redetzky,
M. Witzenrath,
T. Zoller,
A. Uhrig,
B. Opitz,
N. Suttorp,
T. Kramer,
L. Sander,
M. Stegemann and
F. Kurth,
"Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study",
Infection,
vol. 50,
no. 6,
pp. 1441—1452,
2022.
| DOI: | 10.1007/s15010-022-01796-w |
A. Walker,
T. Houwaart,
P. Finzer,
L. Ehlkes,
A. Tyshaieva,
M. Damagnez,
D. Strelow,
A. Duplessis,
J. Nicolai,
T. Wienemann,
T. Tamayo,
M. Kohns Vasconcelos,
L. Hülse,
K. Hoffmann,
N. Lübke,
S. Hauka,
M. Däumer,
A. Thielen,
S. Kolbe-Busch,
K. Göbels,
R. Zotz,
K. Pfeffer,
J. Timm and
A. Dilthey,
"Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting",
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
vol. 74,
no. 6,
pp. 1039—1046,
2022.
| DOI: | 10.1093/cid/ciab588 |
A. Dulovic and
et al,
"Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany",
Frontiers in Immunology,
vol. 13,
pp. 828053,
2022.
| DOI: | 10.3389/fimmu.2022.828053 |
P. Georg,
R. Astaburuaga-García,
L. Bonaguro,
S. Brumhard,
L. Michalick and
e. a. Lippert,
"Complement activation induces excessive T cell cytotoxicity in severe COVID-19",
Cell,
vol. 185,
pp. 493—512.e425,
2022.
J. Brandner,
P. Boor,
L. Borcherding and
et al,
"Contamination of personal protective equipment during COVID-19 autopsies",
Virchows Arch,
pp. 1-10,
2022.
| DOI: | 10.1007/s00428-021-03263-7 |
C. Scheer,
L. Fiedler-Lacombe,
D. Stahl,
M. Nauck,
W. Hoffmann,
E. Schäfer,
K. Saljé,
A. Fritz,
T. Kohlmann,
N. Hübner,
M. Napp,
B. Rauch,
U. Völker,
S. Felix,
G. Lucchese,
A. Flöel,
S. Engeli,
K. Hahnenkamp and
M. Tzvetkov,
"Course of disease and risk factors for hospitalization in outpatients with a SARS‑CoV‑2 infection.",
SCIENTIFIC REPORTS. (open access) 2022; 12(1):7249,
2022.
E. Schäfer,
C. Scheer,
K. Saljé,
A. Fritz,
T. Kohlmann,
N. Hübner,
M. Napp,
L. Fiedler-Lacombe,
D. Stahl,
B. Rauch,
M. Nauck,
U. Völker,
S. Felix,
G. Lucchese,
A. Flöel,
S. Engeli,
W. Hoffmann,
K. Hahnenkamp and
M. Tzvetkov,
"Course of disease and risk factors for hospitalization in outpatients with a SARS‑CoV‑2 infection.",
SCIENTIFIC REPORTS. (open access) 2022; 12(1):7249,
2022.
A. Mardiko,
S. Heinemann,
A. Bludau,
H. Kaba,
A. Leha,
N. von Maltzahn,
N. Mutters,
R. Leistner,
F. Mattner and
S. Scheithauer,
"COVID-19 vaccination strategy for hospital staff in Germany: a cross-sectional study in March-April 2021",
The Journal of hospital infection,
vol. 126,
pp. 87—92,
2022.
| DOI: | 10.1016/j.jhin.2022.05.012 |
A. A. Mardiko,
S. Heinemann,
A. Bludau,
H. E. J. Kaba,
A. Leha,
N. Maltzahn,
N. T. Mutters,
R. Leistner,
F. Mattner and
S. Scheithauer,
"COVID-19 vaccination strategy for hospital staff in Germany: a cross-sectional study in March–April 2021",
Journal of Hospital Infection,
2022.
| DOI: | 10.1016/j.jhin.2022.05.012 |
| Datei: | https://doi.org/10.1016/j.jhin.2022.05.012 |
S. Scheithauer,
A. Bludau,
S. Heinemann,
M. Anton and
P. Knolle,
"COVID-19-Impfstrategien für Beschäftigte deutscher Kliniken: Ergebnisse einer Befragung von Leitungen der (Krankenhaus‑)Hygiene im Rahmen des B-FAST-Projektes [COVID-19 vaccination strategy for employees of German hospitals: results of a survey of infection control practitioners within the B-FAST project]",
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz,
2022.
| DOI: | 10.1007/s00103-022-03607-x |
| Datei: | https://doi.org/10.1007/s00103-022-03607-x |
S. Scheithauer,
A. Bludau,
S. Heinemann,
M. Anton and
P. Knolle,
"COVID-19-Impfstrategien für Beschäftigte deutscher Kliniken: Ergebnisse einer Befragung von Leitungen der (Krankenhaus\hbox-)Hygiene im Rahmen des B-FAST-Projektes",
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz,
vol. 65,
no. 12,
pp. 1299—1306,
2022.
| DOI: | 10.1007/s00103-022-03607-x |
L. Radbruch and
C. Bausewein,
"Covid-19: Was die Palliativmedizin leisten kann",
Rheinisches Ärzteblatt,
no. 6,
2022.
P. Tober-Lau and
et al,
"Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections",
Emerging infectious diseases,
vol. 28,
2022.
| DOI: | 10.3201/eid2805.220271 |
L. Meyer-Arndt and
et al,
"Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly",
Journal of immunology,
vol. 208,
pp. 1001–1005,
2022.
| DOI: | 10.4049/jimmunol.2100990 |
H. Chen,
A. Maul‐Pavicic,
M. Holzer and
et al,
"Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel",
EMBO Mol Med,
vol. 14,
no. 1,
2022.
| DOI: | 10.15252/emmm.202114182 |
| Datei: | https://doi.org/10.15252/emmm.202114182 |
H. Chen and
et al,
"Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel",
EMBO Mol Med,
vol. 14,
pp. e14182,
2022.
| DOI: | 10.15252/emmm.202114182 |
M. Tauchert,
I. Bernemann,
A. Kühn-Steven,
V. Kopfnagel,
S. Kunze,
T. Illig and
G. Anton,
"Digital knowledge management within the NAPKON study.",
Nationales Biobanken Symposium Abstract 11,
2022.
M. Tauchert,
I. Bernemann,
A. Kühn-Steven,
V. Kopfnagel,
S. Kunze,
T. Illig and
G. Anton,
"Digital knowledge management within the NAPKON study. Abstract. 11. Nationales Biobanken Symposium. 2022",
Not available,
2022.
K. Vanshylla and
et al,
"Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults",
The Lancet Infectious Diseases,
vol. 22,
pp. 445–446,
2022.
| DOI: | 10.1016/S1473-3099(22)00135-9 |
[en]
F. Heinrich,
C. Romich,
T. Zimmermann,
I. Kniep,
A. Fitzek,
S. Steurer,
M. Glatzel,
D. Nörz,
T. Günther,
M. Czech-Sioli,
N. Fischer,
A. Grundhoff,
M. Lütgehetmann and
B. Ondruschka,
"Dying of VOC-202012/01 — multimodal investigations in a death case of the SARS-CoV-2 variant",
International Journal of Legal Medicine,
vol. 136,
no. 1,
pp. 193—202,
Jan.
2022.
Abstract:
The current pandemic with Severe acute respiratory syndrome-coronavirus-2 has been taking on new dynamics since the emergence of new variants last fall, some of them spreading more rapidly. Many countries currently find themselves in a race to ramp up vaccination strategies that have been initiated and a possible third wave of the pandemic from new variants, such as the Variant of Concern-202012/01 from the B.1.1.7 lineage. Until today, many investigations in death cases of Coronavirus-disease-19 have been conducted, revealing pulmonary damage to be the predominant feature of the disease. Thereby, different degrees of macroscopic and microscopic lung damage have been reported, most of them resembling an Acute Respiratory Distress Syndrome. Far more, systemic complications of the disease such as pulmonary embolisms have been described. However, neither morphologic nor virologic findings of patients dying of the new variants have yet been reported. Here, we report on a comprehensive analysis of radiologic, morphologic, and virologic findings in a fatal case of this variant.
| DOI: | 10.1007/s00414-021-02618-8 |
| Datei: | https://doi.org/10.1007/s00414-021-02618-8 |
Abstract:
The current pandemic with Severe acute respiratory syndrome-coronavirus-2 has been taking on new dynamics since the emergence of new variants last fall, some of them spreading more rapidly. Many countries currently find themselves in a race to ramp up vaccination strategies that have been initiated and a possible third wave of the pandemic from new variants, such as the Variant of Concern-202012/01 from the B.1.1.7 lineage. Until today, many investigations in death cases of Coronavirus-disease-19 have been conducted, revealing pulmonary damage to be the predominant feature of the disease. Thereby, different degrees of macroscopic and microscopic lung damage have been reported, most of them resembling an Acute Respiratory Distress Syndrome. Far more, systemic complications of the disease such as pulmonary embolisms have been described. However, neither morphologic nor virologic findings of patients dying of the new variants have yet been reported. Here, we report on a comprehensive analysis of radiologic, morphologic, and virologic findings in a fatal case of this variant.
N. Koerber,
A. Priller,
S. Yazici and
et al,
"Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents",
Nat Commun,
vol. 13,
no. 1,
2022.
| DOI: | 10.1038/s41467-021-27649-y |
et al,
"Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies",
Journal of Clinical Immunology,
2022.
| DOI: | 10.1007/s10875-022-01252-2 |
[en]
M. Guarino,
V. Cossiga,
I. Esposito,
A. Furno and
F. Morisco,
"Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!",
Journal of Hepatology,
vol. 76,
no. 1,
pp. 237—239,
Jan.
2022.
| DOI: | 10.1016/j.jhep.2021.07.034 |
| Datei: | https://www.sciencedirect.com/science/article/pii/S0168827821019619 |
K. Kades,
J. Scherer,
J. Scholtyssek,
T. Penzkofer,
M. Nolden and
K. Maier-Hein,
"Efficient DICOM Image Tagging and Cohort Curation Within Kaapana",
Informatik aktuell,
pp. 279-284,
2022.
| DOI: | 10.1007/978-3-658-36932-3_59 |
| Datei: | https://doi.org/10.1007/978-3-658-36932-3_59 |
M. Pietzner,
R. L. Chua,
E. Wheeler,
K. Jechow,
H. Radbruch and
e. a. Trump,
"ELF5 is a respiratory epithelial cell-specific risk gene for severe COVID-19",
medRxiv,
2022.
| DOI: | 10.1101/2022.01.17.22269283 |
S. Hopff,
K. Tilch,
M. Kraus,
L. Lorenz-Depiereux,
G. Anton,
K. Appel,
T. Bahmer,
A. Bartschke,
C. Bellinghausen,
I. Bernemann and
D. Stahl,
"Ethical and coordinative challenges in setting up a national cohort study exemplified by the German National Pandemic Cohort Network (NAPKON)",
Abstract ECCMID 2022,
2022.
K. Antoniou,
E. Vasarmidi,
A. Russell,
B. Crestani,
M. Delcroix,
A. Dinh-Xuan,
V. Poletti,
N. Sverzellati,
M. Vitacca,
M. Witzenrath,
T. Tonia and
A. Spanevello,
"European Respiratory Society statement on long COVID follow-up",
Eur Respir J,
vol. 60,
no. 2,
pp. 2102174,
2022.
| DOI: | 10.1183/13993003.02174-2021 |
L. Krüger,
J. Klein,
F. Tobian and
D. Stahl,
"Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2",
Infection,
vol. 50,
2022.
| DOI: | 10.1007/s15010-021-01681-y |
| Datei: | https://doi.org/10.1007/s15010-021-01681-y |
M. Hoffmann and
et al,
"Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy",
mBio,
2022.
| DOI: | 10.1128/mbio.00364-22 |
H. Meyer,
A. Wienke and
A. Surov,
"Extrapulmonary CT Findings Predict In-Hospital Mortality in COVID-19. A Systematic Review and Meta-Analysis",
Academic radiology,
vol. 29,
no. 1,
pp. 17-30,
Jan.
2022.
Abstract:
Several prognostic factors have been identified for COVID-19 disease. Our aim was to elucidate the influence of non-pulmonary findings of thoracic computed tomography (CT) on unfavorable outcomes and in-hospital mortality in COVID-19 patients based on a large patient sample. MEDLINE library, Cochrane and SCOPUS databases were screened for the associations between CT-defined features and mortality in COVID-19 patients up to June 2021. In total, 22 studies were suitable for the analysis, and included into the present analysis. Overall, data regarding 4 extrapulmonary findings could be pooled: pleural effusion, pericardial effusion, mediastinal lymphadenopathy, and coronary calcification. The included studies comprised 7859 patients. The pooled odds ratios for the effect of the identified extrapulmonary findings on in-hospital mortality are as follows: pleural effusion, 4.60 (95% CI 2.97-7.12); pericardial effusion, 1.29 (95% CI 0.83-1.98); coronary calcification, 2.68 (95% CI 1.78-4.04); mediastinal lymphadenopathy, 2.02 (95% CI 1.18-3.45). Pleural effusion, mediastinal lymphadenopathy and coronary calcification have a relevant association with in-hospital mortality in COVID-19 patients and should be included as prognostic biomarker into clinical routine.
| DOI: | 10.1016/j.acra.2021.10.001 |
| Datei: | https://pubmed.ncbi.nlm.nih.gov/34772618/ |
Abstract:
Several prognostic factors have been identified for COVID-19 disease. Our aim was to elucidate the influence of non-pulmonary findings of thoracic computed tomography (CT) on unfavorable outcomes and in-hospital mortality in COVID-19 patients based on a large patient sample. MEDLINE library, Cochrane and SCOPUS databases were screened for the associations between CT-defined features and mortality in COVID-19 patients up to June 2021. In total, 22 studies were suitable for the analysis, and included into the present analysis. Overall, data regarding 4 extrapulmonary findings could be pooled: pleural effusion, pericardial effusion, mediastinal lymphadenopathy, and coronary calcification. The included studies comprised 7859 patients. The pooled odds ratios for the effect of the identified extrapulmonary findings on in-hospital mortality are as follows: pleural effusion, 4.60 (95% CI 2.97-7.12); pericardial effusion, 1.29 (95% CI 0.83-1.98); coronary calcification, 2.68 (95% CI 1.78-4.04); mediastinal lymphadenopathy, 2.02 (95% CI 1.18-3.45). Pleural effusion, mediastinal lymphadenopathy and coronary calcification have a relevant association with in-hospital mortality in COVID-19 patients and should be included as prognostic biomarker into clinical routine.
[en]
J. Menger,
S. Apostolidou,
C. Edler,
I. Kniep,
R. Kobbe,
D. Singer and
J. Sperhake,
"Fatal outcome of SARS-CoV-2 infection (B1.1.7) in a 4-year-old child",
International Journal of Legal Medicine,
vol. 136,
no. 1,
pp. 189—192,
Jan.
2022.
| DOI: | 10.1007/s00414-021-02687-9 |
| Datei: | https://doi.org/10.1007/s00414-021-02687-9 |
S. Woon,
M. Sheppard and
et al,
"First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction",
J Clin Immunol,
2022.
| DOI: | 10.1007/s10875-021-01187-0 |
S. Von Stillfried,
R. Bülow,
R. Röhrig,
P. Boor and
D. Collaborators,
"First report from the German COVID-19 autopsy registry",
The Lancet Regional Health - Europe,
pp. 100330,
2022.
| DOI: | 10.1016/j.lanepe.2022.100330 |
F. Steinbeis,
P. Knape,
M. Mittermaier,
E. Helbig,
P. Tober-Lau,
C. Thibeault,
L. Lippert,
W. Xiang,
M. Müller-Plathe,
S. Steinbrecher and
D. Stahl,
"Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents",
Respir Med,
vol. 202,
pp. 106968,
2022.
| DOI: | 10.1016/j.rmed.2022.106968 |
A. Kühnapfel,
K. Horn,
U. Klotz,
M. Kiehntopf,
M. Rosolowski,
M. Loeffler,
N. Suttorp,
M. Witzenrath and
M. Scholz,
"Genetic Regulation of Cytokine Response in Patients with Acute Community-Acquired Pneumonia",
Genes (Basel),
vol. 13,
no. 1,
pp. 111,
2022.
| DOI: | 10.3390/genes13010111 |
A. Kühnapfel,
K. Horn,
U. Klotz,
M. Kiehntopf,
M. Rosolowski,
M. Loeffler,
N. Suttorp,
M. Witzenrath and
M. Scholz,
"Genetic Regulation of Cytokine Response in Patients with Acute Community-Acquired Pneumonia. Genes (Basel).",
2022.
R. Dannebaum,
P. Suwalski,
H. Asgharian,
Z. G. Du,
H. Lin,
J. Weiner,
M. Holtgrewe,
C. Thibeault,
M. Müller,
X. Wang and
D. Stahl,
"Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19",
EClinicalMedicine,
vol. 48,
pp. 101438,
2022.
| DOI: | 10.1016/j.eclinm.2022.101438 |
R. Dannebaum,
P. Suwalski,
H. Asgharian,
Z. G. Du,
J. Weiner,
M. Holtgrewe,
C. Thibeault,
M. Müller,
X. Wang,
J. Saccomanno,
J. Doehn,
R. Hübner,
N. Suttorp,
M. Witzenrath,
S. Hippenstiel,
L. E. Sander,
F. Kurth,
P. Group,
H. Lin,
Z. Karadeniz,
B. Hinzmann,
A. Blüher,
S. Siemann,
D. Telman,
C. Skurk,
W. Poller,
D. Beule,
T. Guettouche,
U. Landmesser,
J. Berka,
K. Luong,
F. Rubelt and
B. Heidecker,
"Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19.",
EClinicalMedicine.2022;48:101438,
2022.
K. Hönzke,
B. Obermayer,
C. Mache,
D. Fathykova,
M. Kessler,
S. Dökel,
E. Wyler,
M. Baumgardt,
A. Löwa,
K. Hoffmann and
D. Stahl,
"Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages",
Eur Respir J,
vol. 60,
no. 6,
pp. 2102725,
2022.
| DOI: | 10.1183/13993003.02725-2021 |
K. Hönzke,
B. Obermayer,
C. Mache,
D. Fathykova,
M. Kessler and
e. a. Dökel,
"Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages",
Eur Respir J,
vol. 60,
no. 6,
pp. 2102725,
2022.
| DOI: | 10.1183/13993003.02725-2021 |
H. Kardas,
M. Thormann,
C. Bär,
J. Omari,
A. Wienke,
M. Pech and
A. Surov,
"Impact of Pectoral Muscle Values on Clinical Outcomes in Patients With Severe Covid-19 Disease",
In vivo (Athens, Greece),
vol. 36,
no. 1,
pp. 375-380,
2022.
Abstract:
The effect of sarcopenia on patients with severe Covid-19 disease is unknown. We aimed to assess the influence of baseline computed tomography (CT)-based body composition parameters (pectoralis muscle area, pectoralis muscle index, skeletal muscle gauge) on clinical variables in patients with severe Covid-19 disease. Chest CT scans of adult patients with confirmed Covid-19 who were hospitalized from March 2020 to May 2021 at a level-one medical center in Germany were retrospectively analyzed. Pectoralis muscle area, pectoralis muscle index and skeletal muscle gauge were measured on the first CT scan after admission. Body composition parameters were assessed for association with clinical variables and 30-day mortality. A total of 46 patients were included. None of the body composition parameters was a predictor for 30-day mortality, duration of hospital stay, duration of intensive care unit treatment, or duration of invasive mechanical ventilation. Pectoralis muscle composition parameters in CT chest scans did not predict outcomes in adult patients with severe Covid-19 infection.
| DOI: | 10.21873/invivo.12713 |
| Datei: | https://pubmed.ncbi.nlm.nih.gov/34972737/ |
Abstract:
The effect of sarcopenia on patients with severe Covid-19 disease is unknown. We aimed to assess the influence of baseline computed tomography (CT)-based body composition parameters (pectoralis muscle area, pectoralis muscle index, skeletal muscle gauge) on clinical variables in patients with severe Covid-19 disease. Chest CT scans of adult patients with confirmed Covid-19 who were hospitalized from March 2020 to May 2021 at a level-one medical center in Germany were retrospectively analyzed. Pectoralis muscle area, pectoralis muscle index and skeletal muscle gauge were measured on the first CT scan after admission. Body composition parameters were assessed for association with clinical variables and 30-day mortality. A total of 46 patients were included. None of the body composition parameters was a predictor for 30-day mortality, duration of hospital stay, duration of intensive care unit treatment, or duration of invasive mechanical ventilation. Pectoralis muscle composition parameters in CT chest scans did not predict outcomes in adult patients with severe Covid-19 infection.
S. Bernatz,
S. Afat,
A. E. Othman,
K. Nikolaou,
M. Sieren,
M. Sähn,
D. Pinto Dos Santos,
T. Penzkofer,
A. M. Bucher,
B. Hamm,
T. J. Vogl and
B. Bodelle,
"Impact of the COVID-19 Pandemic on Radiology in Inpatient and Outpatient Care in Germany: A Nationwide Survey Regarding the First and Second Wave",
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
vol. 194,
no. 1,
pp. 70-82,
Jan.
2022.
Abstract:
To find out the opinion of radiological inpatient and outpatient medical staff regarding the measures taken in relation to the COVID-19 pandemic during the first and second waves and to identify the measures that are still perceived as needing improvement. We conducted an anonymous online survey among more than 10 000 radiologists/technicians in Germany from January 5 to January 31, 2021. A total of 862 responses (head physicians, n = 225 [inpatient doctors, n = 138; outpatient doctors, n = 84; N/A, n = 3]; radiologic personnel, n = 637 [inpatient doctor, n = 303; outpatient doctor, n = 50; inpatient technician, n = 217; outpatient technician, n = 26; N/A, n = 41]) were received. Questions of approximation, yes/no questions, and Likert scales were used. During the first/second wave, 70 % (86/123)/43 % (45/104) of inpatient and 26 % (17/66)/10 % (5/52) of outpatient head physicians agreed that they received financial support from the authorities but the majority rated the financial support as insufficient. During the first and second wave, 33 % (8/24) and 80 % (16/20) of outpatient technicians agreed that they were adequately provided with personal protective equipment. The perceived lack of personal protective equipment improved for all participants during the second wave. Inpatient [outpatient] technicians perceived an increased workload in the first and second wave: 72 % (142/198) [79 % (19/24)] and 84 % (146/174) [80 % (16/20)]. Technicians seem increasingly negatively affected by the COVID-19 pandemic in Germany. Financial support by the competent authorities seems to be in need of improvement. · The accessibility of personal protective equipment resources improved in the second wave.. · In particular, radiology technicians seem increasingly negatively affected by the COVID-19 pandemic.. · Financial and consulting support from the government could be improved.. · Bernatz S, Afat S, Othman AE et al. Impact of the COVID-19 Pandemic on Radiology in Inpatient and Outpatient Care in Germany: A Nationwide Survey Regarding the First and Second Wave. Fortschr Röntgenstr 2022; 194: 70 - 82.
| DOI: | 10.1055/a-1586-3278 |
| Datei: | https://pubmed.ncbi.nlm.nih.gov/34649286/ |
Abstract:
To find out the opinion of radiological inpatient and outpatient medical staff regarding the measures taken in relation to the COVID-19 pandemic during the first and second waves and to identify the measures that are still perceived as needing improvement. We conducted an anonymous online survey among more than 10 000 radiologists/technicians in Germany from January 5 to January 31, 2021. A total of 862 responses (head physicians, n = 225 [inpatient doctors, n = 138; outpatient doctors, n = 84; N/A, n = 3]; radiologic personnel, n = 637 [inpatient doctor, n = 303; outpatient doctor, n = 50; inpatient technician, n = 217; outpatient technician, n = 26; N/A, n = 41]) were received. Questions of approximation, yes/no questions, and Likert scales were used. During the first/second wave, 70 % (86/123)/43 % (45/104) of inpatient and 26 % (17/66)/10 % (5/52) of outpatient head physicians agreed that they received financial support from the authorities but the majority rated the financial support as insufficient. During the first and second wave, 33 % (8/24) and 80 % (16/20) of outpatient technicians agreed that they were adequately provided with personal protective equipment. The perceived lack of personal protective equipment improved for all participants during the second wave. Inpatient [outpatient] technicians perceived an increased workload in the first and second wave: 72 % (142/198) [79 % (19/24)] and 84 % (146/174) [80 % (16/20)]. Technicians seem increasingly negatively affected by the COVID-19 pandemic in Germany. Financial support by the competent authorities seems to be in need of improvement. · The accessibility of personal protective equipment resources improved in the second wave.. · In particular, radiology technicians seem increasingly negatively affected by the COVID-19 pandemic.. · Financial and consulting support from the government could be improved.. · Bernatz S, Afat S, Othman AE et al. Impact of the COVID-19 Pandemic on Radiology in Inpatient and Outpatient Care in Germany: A Nationwide Survey Regarding the First and Second Wave. Fortschr Röntgenstr 2022; 194: 70 - 82.
B. Sedlmayr,
M. Sedlmayr,
C. Schüttler and
et al,
"Improving collaborative COVID-19 research of University Hospitals in Germany: Formative usability evaluation of the CODEX-Feasibility Portal",
Appl Clin Inform,
vol. 13,
pp. 400—409,
2022.
| DOI: | 10.1055/s-0042-1744549 |
P. R. Wratil,
N. A. Schmacke,
A. Osterman and
et al,
"In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers",
Infection,
vol. 50,
2022.
| DOI: | 10.1007/s15010-021-01672-z |
N. Dragano,
M. Reuter,
A. Peters,
M. Engels,
B. Schmidt,
K. Greiser,
B. Bohn,
S. Riedel-Heller,
A. Karch,
R. Mikolajczyk,
G. Krause,
O. Lang,
L. Panreck,
M. Rietschel,
H. Brenner,
B. Fischer,
C. Franzke,
S. Gastell,
B. Holleczek,
K. Jöckel,
R. Kaaks,
T. Keil,
A. Kluttig,
O. Kuß,
N. Legath,
M. Leitzmann,
W. Lieb,
C. Meinke-Franze,
K. Michels,
N. Obi,
T. Pischon,
I. Feinkohl,
S. Rospleszcz,
T. Schikowski,
M. Schulze,
A. Stang,
H. Völzke,
S. Willlich,
K. Wirkner,
H. Zeeb and
K. Berger,
"Increase in mental disorders during the COVID-19 pandemic - the role of occupational and financial strains. An analysis of the German National Cohort (NAKO) Study",
Deutsches Ärzteblatt International,
vol. 119,
pp. 179–187,
2022.
| DOI: | 10.3238/arztebl.m2022.0133 |
A. Bludau,
S. Heinemann,
A. Mardiko,
H. Kaba,
A. Leha,
N. von Maltzahn,
N. Mutters,
R. Leistner,
F. Mattner and
S. Scheithauer,
"Infection control strategies for patients and accompanying persons during the COVID-19 pandemic in German hospitals: a cross-sectional study in March-April 2021",
The Journal of hospital infection,
vol. 125,
pp. 28—36,
2022.
| DOI: | 10.1016/j.jhin.2022.03.014 |
A. Bludau,
S. Heinemann,
A. Mardiko,
H. Kaba,
A. Leha,
N. von Maltzahn,
N. Mutters,
R. Leistner,
F. Mattner and
S. Scheithauer,
"Infection control strategies for patients and accompanying persons during the COVID-19 pandemic in German hospitals: a cross-sectional study in March–April 2021",
Journal of Hospital Infection,
vol. 125,
pp. 28-36,
2022.
| DOI: | 10.1016/j.jhin.2022.03.014. |
A. Bludau,
S. Heinemann,
A. Mardiko,
H. Kaba,
A. Leha,
N. von Maltzahn,
N. Mutters,
R. Leistner,
F. Mattner and
S. Scheithauer,
"Infection control strategies for patients and accompanying persons during the COVID-19 pandemic in German hospitals: a cross-sectional study in March–April 2021",
Journal of Hospital Infection,
vol. 125,
pp. 28-36,
2022.
| DOI: | 10.1016/j.jhin.2022.03.014. |
A. Bludau,
S. Heinemann,
A. A. Mardiko,
H. E. J. Kaba,
A. Leha,
N. Maltzahn,
N. T. Mutters,
R. Leistner,
F. Mattner and
S. Scheithauer,
"Infection control strategies for patients and accompanying persons during the COVID-19 pandemic in German hospitals: a cross-sectional study in March–April 2021",
Journal of Hospital Infection,
2022.
| DOI: | 10.1016/j.jhin.2022.03.014 |
| Datei: | https://doi.org/10.1016/j.jhin.2022.03.014 |
T. Houwaart,
S. Belhaj,
E. Tawalbeh,
D. Nagels,
Y. Fröhlich,
P. Finzer,
P. Ciruela,
A. Sabrià,
M. Herrero,
C. Andrés,
A. Antón,
A. Benmoumene,
D. Asskali,
H. Haidar,
J. von Dahlen,
J. Nicolai,
M. Stiller,
J. Blum,
C. Lange,
C. Adelmann,
B. Schroer,
U. Osmers,
C. Grice,
P. Kirfel,
H. Jomaa,
D. Strelow,
L. Hülse,
M. Pigulla,
P. Kreuzer,
A. Tyshaieva,
J. Weber,
T. Wienemann,
M. Kohns Vasconcelos,
K. Hoffmann,
N. Lübke,
S. Hauka,
M. Andree,
C. Scholz,
N. Jazmati,
K. Göbels,
R. Zotz,
K. Pfeffer,
J. Timm,
L. Ehlkes,
A. Walker,
A. Dilthey and
German COVID-19 OMICS Initiative (DeCOI),
"Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021",
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
vol. 27,
no. 43,
2022.
| DOI: | 10.2807/1560-7917.ES.2022.27.43.2101089 |